← All investors
LabCorp
20 portfolio companies · 3 on the map · $37.7M raised · 3 cities
Portfolio map
3 LabCorp portfolio companies on the map.
Portfolio companies
Outcomes4Me
Boston
Outcomes4Me develops direct-to-patient AI-driven platform designed to assist cancer patients in managing their care.
Wellness and Fitness Services$37.7MEst. 2017
Geneoscopy
St. Louis
Geneoscopy develops a screening methodology to noninvasively diagnose colorectal cancer using biomarkers in stool samples.
Biotechnology ResearchSeries CEst. 2015Sera Prognostics
Salt Lake City
Sera Prognostics develops blood tests that are predictive of preterm birth, preeclampsia, and other pregnancy complications.
Biotechnology ResearchPublicEst. 2008
More portfolio companies
17 more LabCorp investments we track beyond the map.
YourBio HealthMedford · Series C
Flatiron HealthNew York · Series B
PathAIBoston · Series C
PetDxLa Jolla · Series B
Vital BioToronto · Series A
PreciseDxNew York · Series B
Navigating CancerSeattle · Series D
AdelaFoster City · Series A
CND Life SciencesScottsdale · Series A
Prognos HealthNew York · Venture
KIYATECGreenville · Series C
Cofactor GenomicsSan Francisco · Venture
Phenomix SciencesRochester · Series A
OmniSeqBuffalo · Series B
OlarisFramingham · Series B
Weavr HealthCambridge · Series A
TrakCelCardiff · Corporate
Portfolio map
3 LabCorp portfolio companies on the map.